Issued Patents All Time
Showing 1–22 of 22 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12162849 | Synthesis of 3-methyl-1,2,4-thiadiazole-5-carbohydrazide or of the methyl-d3 deuterated form thereof | Hamid R. Hoveyda | 2024-12-10 |
| 12091400 | Piperidine derivatives as METTL3 inhibitors | Graeme L. Fraser, Catherine SORLET, Killian OUKOLOFF, Francois Lenoir, Julien KORAC | 2024-09-17 |
| 12054457 | Polymorphs of (2S,5R)-5-(2-chlorophenyl)-1-(2′-methoxy-[1,1′-biphenyl]-4-carbonyl)pyrrolidine-2-carboxylic acid and preparation processes thereof | — | 2024-08-06 |
| 11731974 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Graeme L. Fraser | 2023-08-22 |
| 10941151 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2021-03-09 |
| 10836768 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Graeme L. Fraser | 2020-11-17 |
| 10787458 | Chiral synthesis of N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-A]pyrazines | Hamid R. Hoveyda | 2020-09-29 |
| 10683295 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-A]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2020-06-16 |
| 10544150 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Graeme L. Fraser | 2020-01-28 |
| 10214533 | N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Graeme L. Fraser | 2019-02-26 |
| 10183948 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Graeme L. Fraser | 2019-01-22 |
| 10065960 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Graeme L. Fraser | 2018-09-04 |
| 10065961 | Chiral N-acyl-5,6,7,(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2018-09-04 |
| 10030025 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Graeme L. Fraser | 2018-07-24 |
| 9987274 | N-acyl-(3-substituted)-(8-substituted)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Graeme L. Fraser | 2018-06-05 |
| 9969745 | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Graeme L. Fraser | 2018-05-15 |
| 9969738 | N-acyl-(3-substituted)-5,6,7,8-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Graeme L. Fraser | 2018-05-15 |
| 9926325 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Graeme L. Fraser | 2018-03-27 |
| 9840508 | N-acyl-(3-substituted)-(8-methyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a] pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor-mediated disorders | Hamid R. Hoveyda, Graeme L. Fraser | 2017-12-12 |
| 9475814 | Chiral N-acyl-5,6,7(8-substituted)-tetrahydro-[1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists, pharmaceutical composition, methods for use in NK-3 receptor mediated disorders and chiral synthesis thereof | Hamid R. Hoveyda, Graeme L. Fraser, Marie-Odile Roy, Mohamed El Bousmaqui, Frederic Batt | 2016-10-25 |
| 9422299 | Substituted [1,2,4]triazolo[4,3-a]pyrazines as selective NK-3 receptor antagonists | Hamid R. Hoveyda, Graeme L. Fraser | 2016-08-23 |
| 8871761 | NK-3 receptor selective antagonist compounds, pharmaceutical composition and methods for use in NK-3 receptors mediated disorders | Hamid R. Hoveyda, Marie-Odile Roy, Graeme L. Fraser | 2014-10-28 |